ARTICLE | Financial News

Coronado raises $21.6 million

November 5, 2010 12:26 AM UTC

Coronado Biosciences Inc. (New York, N.Y.) raised $21.6 million through a series of private financings led by Paramount BioCapital. Coronado, which was founded in 2007, also said it hired Glenn Cooper as executive chairman and acting CEO, and Eric Rowinsky as vice chairman. Cooper previously was chairman and CEO of Indevus Pharmaceuticals Inc., which was acquired by Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP) in 2009. Rowinsky was EVP and CMO at ImClone Systems Inc., now part of Eli Lilly and Co. (NYSE:LLY). ...